[Media Releases] Accelerating drug discovery process (Biospectrum, 26 Mar 2012)
Title: Accelerating drug discovery process Publication: Biospectrum Date: 26 Mar 2012 URL: link to website
· LegoChem Biosciences is working on faster and more efficient drug discovery and development of new small molecules. · They enable discovery of new small molecule drugs faster and more efficiently by combining their core technology, LegoChemistry, with early absorption, distribution, metabolism, excretion and toxicity (ADMET) screening platform technologies. · LegoChem Biosciences is committed to building sustainable pipelines in therapeutic areas of antibiotics, anti-coagulants, anti-cancer and antibody-drug conjugate (ADC) platform technology.
About LegoChem Biosciences LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC). |